Visit COVID-19 resources

[Skip to Content]

Welcome message from the new Editor-in-Chief of ‘EYE’, the scientific journal of RCOphth

Jan 24
2018

On behalf of the Editorial Board of EYE, its authors and readers, I would like to thank our outgoing Editor-in Chief, Professor Andrew Lotery, who has invested significant efforts to advance the profile of EYE. I am honoured to assume the responsibilities of Editor-in-Chief of EYE. I am grateful to The Royal College of Ophthalmologists

  • 24 January 2018

New NICE Age Related Macular Degeneration guidance supports potential cost savings for the NHS

Jan 23
2018

NHS Clinical Commissioners (NHSCC) and The Royal College of Ophthalmologists (RCOphth) welcome the publication today of guidance from the National Institute for Health and Care Excellence (NICE) which we believe can help to secure better value from the significant funds currently being spent on treating wet age related macular degeneration (AMD). In the current NHS

  • 23 January 2018

East of England regional retinopathy of prematurity – (East of England regional retinopathy of prematurity, Published online: 2018-01-19; | doi:10.1038/eye.2017.302)

Jan 19
2018

East of England regional retinopathy of prematurity East of England regional retinopathy of prematurity, Published online: 19 January 2018; doi:10.1038/eye.2017.302 East of England regional retinopathy of prematurity

  • 19 January 2018

Laws of physics help explain capillary non-perfusion in diabetic retinopathy – (Laws of physics help explain capillary non-perfusion in diabetic retinopathy, Published online: 2018-01-19; | doi:10.1038/eye.2017.313)

Jan 19
2018

Laws of physics help explain capillary non-perfusion in diabetic retinopathy Laws of physics help explain capillary non-perfusion in diabetic retinopathy, Published online: 19 January 2018; doi:10.1038/eye.2017.313 Laws of physics help explain capillary non-perfusion in diabetic retinopathy

  • 19 January 2018

A novel mutation (LEU396ARG) in OPA1 is associated with a severe phenotype in a large dominant optic atrophy pedigree – (A novel mutation (LEU396ARG) in OPA1 is associated with a severe phenotype in a large dominant optic atrophy pedigree, Published online: 2018-01-19; | doi:10.1038/eye.2017.303)

Jan 19
2018

A novel mutation (LEU396ARG) in OPA1 is associated with a severe phenotype in a large dominant optic atrophy pedigree A novel mutation (LEU396ARG) in OPA1 is associated with a severe phenotype in a large dominant optic atrophy pedigree, Published online: 19 January 2018; doi:10.1038/eye.2017.303 A novel mutation (LEU396ARG) in OPA1 is associated with a severe

  • 19 January 2018